HbA1c ReductionControl Group Usual Activity

Clinical evidence dossier

Control Group Usual Activity

HbA1c

Evidence signal

Evidence signal

Strong

This is an authoritative evidence signal supplied by Clinical Reference. It is not a formal clinical grade, treatment recommendation, or pooled effect estimate.

Evidence snapshot

Authoritative support records
3
Supporting studies available for review
3
Randomized trials
3
Reported effects
7

Clinical conclusion

Control Group Usual Activity has not shown a clear effect on HbA1c in the available evidence.

The conclusion and evidence-signal classification are distinct authoritative fields and are reproduced as published.

Observed effects

Observed study estimates; not a pooled treatment effect.

Change from baseline

Absolute change

−0.84% to −0.5%

4 eligible estimates12–16 weeksObserved median: −0.7150000000000001%

Change from baseline

Absolute change

0.1 mmol/mol to 0.1 mmol/mol

1 eligible estimates12–12 weeksObserved median: 0.1 mmol/mol

Change from baseline

Mean difference

−7.3 mmol/mol to −7.3 mmol/mol

1 eligible estimates12–12 weeksObserved median: −7.3 mmol/mol

Evidence composition

Non-randomized studies
0
Other designs
0
Unresolved designs
0
Magnitude-eligible effects
6

Consistency

Consistency classification

Mostly consistent

Positive
0
No effect
2
Mixed
0
Negative
1

Population and applicability

Structured population data were available for 3 of 3 supporting studies. 2 studies described participants with type 2 diabetes. 3 studies described adult participants.

This population information refers to the materialized supporting studies available for review. Omitted support records remain part of the authoritative support accounting and are available through the audit experience.

View reported population descriptions

These descriptions are reported across the supporting studies; they are not a single synthesized population.

  • Adults with insulin-treated type 2 diabetes.
  • Individuals seeking alternative dietary strategies for diabetes management.
  • Sedentary adults aged 30-65 years.
  • Individuals diagnosed with prediabetes.
  • Adults diagnosed with Type 2 Diabetes Mellitus.
  • Patients seeking dietary education for diabetes management.

Limitations

No structured limitations are available.

Supporting evidence

Inspect the authoritative studies and omitted support records for this dossier.

View supporting evidence